These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31012563)

  • 1. A Randomized Controlled Tolerability Study to Evaluate Reformulated Benzoyl Peroxide Face Washes for Acne Vulgaris.
    Santos-Caetano JP; Cargill MR
    J Drugs Dermatol; 2019 Apr; 18(4):350-356. PubMed ID: 31012563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
    Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
    Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
    Andres P; Pernin C; Poncet M
    Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled double-blinded split-face prospective clinical trial to assess the efficacy, safety, and tolerability of a novel 3-step routine compared to benzoyl peroxide for the treatment of mild to moderate acne vulgaris.
    Gern A; Walter J; Xu S; Vakharia PP
    Arch Dermatol Res; 2024 May; 316(6):230. PubMed ID: 38787441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is benzoyl peroxide 3% topical gel effective and safe in the treatment of acne vulgaris in Japanese patients? A multicenter, randomized, double-blind, vehicle-controlled, parallel-group study.
    Kawashima M; Hashimoto H; Alio Sáenz AB; Ono M; Yamada M
    J Dermatol; 2014 Sep; 41(9):795-801. PubMed ID: 25132461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
    Schaller M; Sebastian M; Ress C; Seidel D; Hennig M
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):966-73. PubMed ID: 26915831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
    Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
    J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability.
    Kim MR; Kerrouche N
    J Dermatolog Treat; 2018 Feb; 29(1):49-54. PubMed ID: 28678647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
    Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
    Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
    Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
    J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: A secondary publication.
    Kawashima M; Nagare T; Katsuramaki T
    J Dermatol; 2017 Jun; 44(6):635-643. PubMed ID: 28150367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
    Ting W
    Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.